Safety, Tolerability and Efficacy of ISIS-GCGRRx in Type 2 Diabetes

This study has been completed.
Information provided by (Responsible Party):
Isis Pharmaceuticals Identifier:
First received: June 13, 2013
Last updated: November 21, 2014
Last verified: November 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2014
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)